Purpose: Congenital pulmonary airway malformation (CPAM)-a rare developmental anomaly-affects the lower respiratory tract in newborns. By comparing the reliability of diagnostic tools and identifying predictive factors for symptoms, we provide com prehensive clinical data for the proper management of CPAM. Methods: We reviewed the medical records of 66 patients with prenatally diagnosed CPAM delivered at Severance Results: We enrolled 33 boys and 33 girls. Their mean gestational age and birth weight were 38.8 weeks and 3,050 g, respectively. Prenatal ultrasonography and postnatal radiography, lung ultrasonography, and chest computed tomography (CT) showed inconsistent findings. Chest CT showed superior sensitivity (100%) and positive pre dictive value (90%). Among the 66 patients, 59 had postnatally confirmed CPAM, three had pulmonary sequestration, one had cystic teratoma, and one had a normal lung. Of the 59 patients with CPAM, 21 (35%; mean age, 23.4 months) underwent surgery, including 15 who underwent videoassisted thoracoscopy. Twentyfive and 12 patients exhibited respiratory symptoms at birth and during infancy, respectively. Apgar scores and mediastinal shift on radiography were significantly associated with respiratory symptoms at birth. However, none of the factors could predict respiratory symptoms during infancy. Conclusion: Radiography or ultrasonography combined with chest CT can confirm an unclear or inconsistent lesion. Apgar scores and mediastinal shift on radiography can predict respiratory symptoms at birth. However, symptoms during infancy are not associated with prenatal and postnatal factors. Chest CT combined with periodic symptom monitoring is important for diagnosing and managing patients with pre natally diagnosed CPAM and to guide appropriate timing of surgery.
INTRODUCTION
Congenital pulmonary airway malformation (CPAM) is a de velopmental anomaly of the lungs that occurs in 1 in 10,000 to 35,000 newborn infants. It originates from the bronchopulmonary foregut and is caused by delayed pulmonary development at 4 to 7 weeks of gestation 1) . CPAM accounts for 95% of congenital cystic pulmonary lesions, most commonly found via prenatal screening at 18 to 20 weeks of gestation 2) . Predicting the presence and severity of respiratory symptoms in patients with prenatally diagnosed CPAM is difficult, because the use of prenatal ultra sound diagnosis and the role of other associated factors in the presence and onset of symptoms are unclear 3) . As patients with CPAM can possibly undergo malignant transformation and are predisposed to repetitive infection, surgical treatment in the early stages has been the current treatment of choice. However, there is an ongoing controversy regarding elective surgical resection in infants with asymptomatic CPAM 4) .
In this study, we report our experience with the clinical and imaging features as well as the postnatal management of new borns with prenatally diagnosed CPAM at a single tertiary neo natal center over 12 years. By comparing the reliability of imaging tools and identifying potential predictive factors associated with respiratory symptoms at birth and during infancy, we provide comprehensive clinical data that can lead to the proper manage ment of CPAM.
MATERIALS AND METHODS
We conducted a retrospective analysis of the medical records of 66 patients with prenatally diagnosed CPAM delivered at Severance Children's Hospital between January 2005 and July 2017. The histopathological types of CPAM have traditionally been based on the Stocker classification 5) . For newborns with prenatally diagnosed CPAM, postnatal chest radiography, lung ultrasonography, and/or chest computed tomography (CT) were performed. The patients' respiratory symptoms at birth and du ring infancy, history of surgery, surgical methods and outcomes, and postoperative pathological findings were reviewed. We also analyzed the longterm followup data of patients with CPAM at the department of pediatrics and thoracic surgery.
The study protocol was approved by the Institutional Review Board of Severance Hospital, Yonsei University College of Medi cine, Seoul, Korea (420190137). The requirement for informed consent was waived because of the retrospective nature of the study and because the analysis used anonymous clinical data.
Statistical analysis was performed using IBM SPSS Statistics for
Windows/Macintosh, version 23.0 (IBM Corp., Armonk, NY, USA). Noncontinuous variables between the two groups were compared using the chisquare test or Fisher's exact test, and the outcomes were represented as percentages. Continuous vari ables between the two groups were compared using the two sample Ttest or MannWhitney Utest, and the outcomes were represented as mean±standard deviations. All outcomes with P values <0.05 were considered statistically significant.
RESULTS

Characteristics of newborn infants and mothers
The mean gestational age at the time of delivery was 38.8 weeks (38.8±1.4), and the mean birth weight was 3,050 g (3,050±460).
The ratio of boys to girls was 1:1, with 33 patients of each sex.
The mean final followup duration was 48.4 months (48.4± 27.5) ( Table 1 ). The mean Apgar scores for 1 and 5 minutes were 6.4 and 8.0, respectively. The mean age of the mothers was 30.3±4.0 years. Analysis of the obstetric history revealed only one case of accompanying polyhydramnios. The timing of prenatal diagnosis of CPAM was at a gestational age of 22.6 weeks (22.6±3.1).
Postnatal diagnostic examinations
Chest radiography was performed in all patients at birth. Lung and 83%, 70% and 88%, and 100% and 90%, respectively (Table   2 ). Therefore, chest CT was the most reliable imaging technique for diagnosing CPAM.
Accompanying malformations
In the entire patient cohort, 12 had cardiac malformations, seven had kidney malformations, and one had diaphragmatic hernia ( 
Respiratory symptoms at birth and during infancy
We sought to identify the factors associated with clinical symp 
Surgery and complications
Among the 59 patients with CPAM confirmed after birth, 21
(35%) underwent surgery, and the mean age at surgery was 21 months (ranging from birth to 54 months). No significant diffe rence was observed in patient characteristics between the surgery and nonsurgery groups (Table 4 ). However, in the surgery group, the proportion of patients who presented respiratory symptoms at birth was higher (48%) than that in the nonsurgery group (34 %), albeit not statistically significant.
Among the 25 patients presenting respiratory symptoms at birth, three underwent early surgery during the neonatal period. The fresh specimen consists of a product of video-assisted thoracoscopyassisted pneumonectomy, including the right lung. The specimen shows multiple uniform cysts. However, no definite mass-like lesion is observed, which is consistent with type 2 congenital pulmonary airway malformation. predictive factors associated with the occurrence of respiratory symptoms at birth and during infancy, which are essential for postnatal management. Since the diagnosis and management of CPAM remain controversial, by reviewing many patients over a long term, we aimed to provide comprehensive clinical data on CPAM that could lead to its proper management.
CPAM generally occurs in the unilateral form, but exhibits higher incidence on the right side 6) . It may be accompanied by excessive amniotic fluid, nonimmune fetal hydrops, ascites, and mediastinal shift, as well as other structural anomalies. However, CPAM is not associated with chromosomal abnormalities 7) . In . This classification was based on the histological and morpho logical findings of lung lesions obtained via surgery. The original classification initially included three types of CPAM (types 1, 2, and 3), and types 0 and 4 were added later 5, 8) . Type 1 is the most common type. However, in this study, type 2 accounted for the highest proportion (11/21, 52.4%), and no patient had type 0 or 4.
The diagnosis of CPAM requires a multidisciplinary approach involving obstetricians, radiologists, pediatricians, surgeons, and pathologists 9) . As ultrasonography technology has developed, the sensitivity of both prenatal and postnatal diagnosis of CPAM has been increasing 10) . One study reported that the prenatal diag nosis rate of CPAM was as high as 85.7% over 8 years of retro spec tive assessment 11) . Although the sensitivity and specificity of prenatal magnetic resonance imaging is as high as 95%, prenatal ultrasonography is the most commonly used diagnostic method 12) . Lesions may grow until 25 to 28 weeks of gestation, but may partially regress during the third trimester of pregnancy 13) . How ever, the regression of lesions observed under prenatal ultrasono graphy may not result in complete loss of the lesion 14) . In this study, although 15 patients had regression of their lesions, 13
of them displayed lesions after birth. Thus, even if the lesion re gresses during prenatal screening, postnatal imaging is essential for the accurate diagnosis of CPAM. In a previous study assessing 26 patients with prenatally diagnosed CPAM, chest CT was highly sensitive and showed a good positive predictive value that was consistent with our results 15) . Prenatal ultrasonography, post natal chest radiography, or lung ultrasonography alone is not adequately reliable to diagnose CPAM or its complete regression 16) . We suggest chest CT for confirming the diagnosis of CPAM, considering its high sensitivity and positive predictive value. . A B Figure 4 . Pathological findings of a patient with type 1 congenital pulmonary airway malformation. (A) Surgical specimen from the right lung mass measuring 2.5×1.5×1 cm. (B) A pathological analysis reveals multiple cysts in the lung parenchyma, which is consistent with type 1 congenital pulmonary airway malformation. More specifically, CVR ≥1.6 was reported to increase the risk of fetal hydrops 17) . Much attention has been drawn to identifying prognostic factors predicting respiratory outcomes, such as con tralateral lung volume per thoracic volume and the incidence of mediastinal shift 18) . However, many studies failed to identify the prognostic factors predicting the respiratory symptoms in patients with CPAM 19) . In this study, multiple factors were analyzed to identify the prognostic factors for respiratory symptoms at birth and during infancy. CVR was excluded because it was not rou tinely measured in all examinations. Instead, we compared the maximum size of the lesion by measuring its largest dimension reached during pregnancy. In our study, the Apgar scores at 1 and 5 minutes and mediastinal shift on chest radiography were significantly associated with respiratory symptoms at birth. Other factors were found not to be significant.
Different opinions exist regarding the treatment of CPAM. For prenatal treatment, thoracoamniotic shunt or multiple courses of antenatal betamethasone for highrisk fetal CPAM are considered effective 20, 21) . In our study, no patients had received prenatal in tervention. Moreover, the standard for postnatal treatment has not yet been established. If the patient is symptomatic, surgical treatment is recommended 20) . The symptoms include infection, pulmonary hemorrhage, pneumothorax, respiratory difficulty, and malignant transformation. Pneumonectomy is the most commonly used surgical treatment for patients with CPAM, and it has a high success rate 11, 22) . A previous study that assessed 1, 120 infants demonstrated that the thoracoscopic approach induced fewer complications and resulted in shorter hospitalization 23) . In neonates, thoracoscopic intervention may be difficult because of the limited operative space within their small bodies 24) . However, minimalaccess surgery is becoming widespread, and recently published series have reported increased utilization of VATS from 32.2% in 2008 to 48.2% in 2014 23) . . However, even for asymptomatic patients, the possibility of repeated infection and malignant transformation are the reasons for pneumonectomy, which may outweigh the benefits of con servative management. CPAM can occasionally be a cystic mal formation, and it may be a pleuropulmonary blastoma induced by DICER1 mutation, albeit rarely (with an estimated incidence of 1 in 300,000) 20, 25) . During followup, as infants and children are inevitably and repeatedly exposed to radiation from radiological studies, the European Academic Society suggests that only physical examination is required for lesions that are asympto matic and stable until the patient becomes an adult 26) . However, there are concerns suggesting that in the absence of surgical resection, patients and families may experience continuous and unnecessary stress throughout the longterm followup process 20) . A previous study reported that approximately 25% of asympto matic patients with CPAM eventually develop symptoms at an average age of 6 to 7 months, which is different from our findings (2.8±2.2 months) 19) . Our study was performed at a tertiary center to which patients with highrisk CPAM are referred and where a high proportion of respiratory symptoms are seen at birth; 
